Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Infection Reactivation”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Not applicableUnknownNCT01397058
What this trial is testing

Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress

Who this might be right for
Cytomegalovirus ViraemiaStress, PhysiologicalReceptor, Hormonal; Disorder+1 more
University of Athens 275
Testing effectiveness (Phase 2)WithdrawnNCT01326273
What this trial is testing

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

Who this might be right for
CMV ReactivationAllogeneic Stem Cell TransplantationAutologous CMV Specific CD8+ T Cells
Imperial College London
Not applicableStudy completedNCT07181330
What this trial is testing

Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell Transplantation (HSCT)CMV Reactivation+1 more
Ting YANG 60
Large-scale testing (Phase 3)Study completedNCT01077908
What this trial is testing

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

Who this might be right for
Cytomegalovirus Infection
Cell Medica Ltd 89
Early research (Phase 1)UnknownNCT03576014
What this trial is testing

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

Who this might be right for
Cytomegalovirus InfectionsPreventation of Cytomegalovirus ReactivationBK Virus Infection+1 more
SL VAXiGEN 18
Testing effectiveness (Phase 2)Looking for participantsNCT05432778
What this trial is testing

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

Who this might be right for
CMV Viremia
University Medical Centre Ljubljana 90
Not applicableStudy completedNCT02527291
What this trial is testing

Cytomegalovirus Reactivation in Non Immunocompromised Patients Undergoing Cardiac Surgery

Who this might be right for
Cardiac Surgery
Soroka University Medical Center 30
Early research (Phase 1)Looking for participantsNCT05183490
What this trial is testing

R-MVST Cells for Treatment of Viral Infections

Who this might be right for
Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus+1 more
Columbia University 36
Not applicableNot Yet RecruitingNCT07210242
What this trial is testing

HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantationVirus Reactivation+1 more
Ting YANG 300
Early research (Phase 1)WithdrawnNCT05589844
What this trial is testing

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegaloviral InfectionHematopoietic and Lymphoid System Neoplasm
Roswell Park Cancer Institute
Not applicableStudy completedNCT00366717
What this trial is testing

Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy

Who this might be right for
CancerCytomegalovirus
Mackay Memorial Hospital 20
Not applicableLooking for participantsNCT06812598
What this trial is testing

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Who this might be right for
Cytomegalovirus InfectionsCMV
The First Affiliated Hospital of Soochow University 330
Testing effectiveness (Phase 2)UnknownNCT01633476
What this trial is testing

CMV Modulation of the Immune System in ANCA-associated Vasculitis

Who this might be right for
ANCA Associated VasculitisCMV Infection
Professor Lorraine Harper 38
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Testing effectiveness (Phase 2)Study completedNCT03067155
What this trial is testing

CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.

Who this might be right for
Hematological MalignanciesCMV Infection
University Hospital, Ghent 1
Not applicableLooking for participantsNCT06441669
What this trial is testing

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Who this might be right for
Cytomegalovirus Infection Reactivation
Anhui Provincial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01063829
What this trial is testing

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

Who this might be right for
HCMV Reactivation or HCMV End-Organ Disease
AiCuris Anti-infective Cures AG 133
Not applicableEnded earlyNCT02873325
What this trial is testing

Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT

Who this might be right for
Infectious Complications Following HSCT
Cell Medica Ltd 1
Testing effectiveness (Phase 2)Looking for participantsNCT06572462
What this trial is testing

ATG Individualized Dosing Model in URD-PBSCT.

Who this might be right for
Cytomegalovirus InfectionsInfection ReactivationStem Cell Transplant Complications
Chinese PLA General Hospital 30
Load More Results